Harness IP
  • People
  • Global IP Services
    • Practice Areas
    • Industries
    • Case Studies
  • Blog
  • News & Awards
  • About Us
  • Careers
  • Contact Us
    • 한국어
    • 日本語
    • 中國語
  • Client Login
  • 한국어
  • 日本語
  • 中國語

Blog

Stay Current on all things IP by subscribing to our blog

Join

Harness IP takes pride in our collective knowledge of intellectual property law and how it affects businesses and organizations across a range of industries. We also enjoy keeping up with the latest decisions from the prominent venues that affect IP law, including the Federal Circuit, the U.S. Supreme Court, and the PTAB. Our goal is to distill this knowledge into practical guidance that in-house counsel and others can use. We invite you to join our audience and enrich the discussion whenever possible. 

  • Chemistry & Nanotechnology

      ALL CATEGORIES

      • Biologics & Biosimilars
        • FDA Guidance & Updates
      • BioPharma
      • Blockchain, Crypto, & Web 3.0
      • Chemistry & Nanotechnology
      • EDMO Patent Updates
      • Fitness IP
      • IP Management
      • IPR-PGR
      • Litigation
      • Patent Prosecution
      • quIPs
      • Trademarks
      • Uncategorized
  • Authors
    • Caley BennettCaley Bennett 3
    • Jewell N. BriggsJewell N. Briggs 8
    • John A. Castellano, IIIJohn A. Castellano, III 1
    • Christopher M. CaubleChristopher M. Cauble 5
    • Christopher R. ClaytonChristopher R. Clayton 1
    • Matthew L. CutlerMatthew L. Cutler 202
    • Keith P. DriscollKeith P. Driscoll 1
    • Nicholas S. DrysdaleNicholas S. Drysdale 7
    • Monte L. FalcoffMonte L. Falcoff 3
    • Jeremiah J. FoleyJeremiah J. Foley 1
    • Glenn E. ForbisGlenn E. Forbis 12
    • Charlie Franklin, Ph.D.Charlie Franklin, Ph.D. 1
    • Alexandra M. FuchsAlexandra M. Fuchs 3
    • Michael GambleMichael Gamble 1
    • Jordyn GraweJordyn Grawe 11
    • Jason A. HeistJason A. Heist 1
    • Paul R. HofferPaul R. Hoffer 3
    • Michael P. KellaMichael P. Kella 4
    • Hemant M. KeskarHemant M. Keskar 4
    • Sung Pil KimSung Pil Kim 1
    • Elisabeth A. KoralElisabeth A. Koral 12
    • Kisuk LeeKisuk Lee 4
    • Jeffrey LinJeffrey Lin 2
    • J. Bradley (Brad) LuchsingerJ. Bradley (Brad) Luchsinger 1
    • Chris K. MillerChris K. Miller 1
    • Leanne M. RakersLeanne M. Rakers 37
    • Douglas A. RobinsonDouglas A. Robinson 20
    • Joel R. SamuelsJoel R. Samuels 16
    • Mark A. SpinelliMark A. Spinelli 1
    • David L. SuterDavid L. Suter 2
    • Michael L. TaylorMichael L. Taylor 1
    • Jennifer R. TurchynJennifer R. Turchyn 4
    • David P. UtykanskiDavid P. Utykanski 2
    • Michael VarcoMichael Varco 5
    • Colette E. VerchColette E. Verch 1
    • Joseph E. Walsh, Jr.Joseph E. Walsh, Jr. 4
    • Andrew M. WaxmanAndrew M. Waxman 2
    • Bryan K. WheelockBryan K. Wheelock 720
    • Kaylynn WilliamsonKaylynn Williamson 1
    • Jennifer M. Woodside WojtalaJennifer M. Woodside Wojtala 12
    • Scott E. YackeyScott E. Yackey 1
  • CHEMICAL & LIFE SCIENCE PATENTS_Q2 CLS Newsletter

    July 7, 2025

    U.S. Chemical & Life Science Patents Q2 Newsletter

    More

  • 5 Federal Circuit Patent Cases You Need To Know

    June 30, 2025

    5 Federal Circuit Patent Cases You Need To Know

    More

  • Enablement, Anticipation, and Claim Strategy

    June 26, 2025

    Enablement, Anticipation, and Claim Strategy: Rethinking Biotech Patent Drafting Post-Agilent

    More

  • Six Actions to Take to Ensure Your Trade Secret Stays Secret

    June 23, 2025

    Six Actions to Take to Ensure Your Trade Secret Stays Secret

    More

  • GettyImages 2207660420 | Intellectual Property Law Firm | Harness IP

    June 23, 2025

    Cannabis And Trademarks: Protecting Against Infringement

    More

  • The Hypocrisy of ‘Delete IP’

    May 13, 2025

    The Hypocrisy of ‘Delete IP’: Billionaire Frustrations Masquerading as Policy

    More

CHEMICAL & LIFE SCIENCE PATENTS_Q2 CLS Newsletter

July 7, 2025

U.S. Chemical & Life Science Patents Q2 Newsletter

By: Caley Bennett, Associate; Christopher R. Clayton, Associate; Jordyn Grawe, Patent Agent; Elisabeth A. Koral, Principal; Kisuk Lee, Principal; Jeffrey Lin, Associate; Leanne M. Rakers, Principal; Douglas A. Robinson, Principal; Michael Varco, Principal

CLS Newsletter

April 4, 2025

U.S. Chemical & Life Science Patents Quarterly Newsletter

By: Caley Bennett, Associate; Jordyn Grawe, Patent Agent; Michael Varco, Principal; Leanne M. Rakers, Principal

WIPO Standard ST.26 Tips_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP

October 5, 2022

WIPO Standard ST.26 Tips as of 16 August 2022

By: Jordyn Grawe, Patent Agent; Leanne M. Rakers, Principal

WIPO resources_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP

September 28, 2022

WIPO ST.26 Resources

By: Jordyn Grawe, Patent Agent; Leanne M. Rakers, Principal

WIPO sequence features_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP_

September 21, 2022

Features of WIPO Sequence

By: Jordyn Grawe, Patent Agent; Leanne M. Rakers, Principal

WIPO ST.25 vs ST.26_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP_

September 13, 2022

ST.25 vs. ST.26 Sequence Listings

By: Leanne M. Rakers, Principal; Jordyn Grawe, Patent Agent

WIPO ST.26_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP_

September 7, 2022

WIPO ST.26 Overview

By: Jordyn Grawe, Patent Agent; Leanne M. Rakers, Principal

Harness IP_Intellectual Property_The Big Bang Blog Series_WIPO .26 Standards

August 30, 2022

The Big Bang Blog Series – The New WIPO Standard

By:

Patented Life Science Technology

June 19, 2017

Missed opportunity: Federal Circuit Again Offers No Clarifying Insight on Alice’s Two-Step Framework

By: Jewell N. Briggs, Associate

shutterstock 156673100 | Intellectual Property Law Firm | Harness IP

April 28, 2017

Ready, Set, Nano-Race!

By: Jennifer M. Woodside Wojtala, Principal

Chemical Patents Image

March 2, 2017

Chemistry & Nanotechnology Developments to Watch in 2017

By: Jennifer M. Woodside Wojtala, Principal; Leanne M. Rakers, Principal

Harness IP Biopharma Patent Law

February 9, 2017

2016’s Top Patent and Trade Secret Developments for Chemistry and Nanotechnology

By: David L. Suter, Principal; Jennifer M. Woodside Wojtala, Principal; Jewell N. Briggs, Associate; Jennifer R. Turchyn, Principal

Harness IP Biopharma Patent Law

February 9, 2017

USPTO Claim Construction Standards for Inter Partes Review Proceedings

By:

Harness IP Biopharma Patent Law

February 9, 2017

USPTO Standards of Review for Inter Partes Review Proceedings

By:

Harness IP Biopharma Patent Law

February 9, 2017

USPTO Errs in Failing to Carry Burden to Support Rejection

By:

Harness IP Biopharma Patent Law

February 9, 2017

On-Sale Bar for Contractor and Supplier Activities

By: Jennifer M. Woodside Wojtala, Principal; Jason A. Heist, Principal

Harness IP Biopharma Patent Law

February 9, 2017

Federal Trade Secrets Act

By: Jennifer M. Woodside Wojtala, Principal; David L. Suter, Principal; Jewell N. Briggs, Associate

Harness IP Biopharma Patent Law

February 9, 2017

Enhanced Damages for Willful Infringement

By: Jennifer R. Turchyn, Principal

Stay Current on all things IP by subscribing to our blog

Join

  • LinkedIn
  • Facebook
    • Sitemap
    • Privacy Statement
    • Legal Notice

  • © 2025 Harness, Dickey & Pierce, P.L.C. All rights reserved. H D & P